ATE523204T1 - Cd44v6-peptide als bakterielle infektionsinhibitoren - Google Patents
Cd44v6-peptide als bakterielle infektionsinhibitorenInfo
- Publication number
- ATE523204T1 ATE523204T1 AT09002149T AT09002149T ATE523204T1 AT E523204 T1 ATE523204 T1 AT E523204T1 AT 09002149 T AT09002149 T AT 09002149T AT 09002149 T AT09002149 T AT 09002149T AT E523204 T1 ATE523204 T1 AT E523204T1
- Authority
- AT
- Austria
- Prior art keywords
- bacterial infection
- spp
- infection inhibitors
- cd44v6 peptides
- cd44v6
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/178—Lectin superfamily, e.g. selectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09002149A EP2218457B1 (de) | 2009-02-16 | 2009-02-16 | CD44v6-Peptide als bakterielle Infektionsinhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE523204T1 true ATE523204T1 (de) | 2011-09-15 |
Family
ID=40834558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09002149T ATE523204T1 (de) | 2009-02-16 | 2009-02-16 | Cd44v6-peptide als bakterielle infektionsinhibitoren |
Country Status (3)
Country | Link |
---|---|
US (2) | US20100305026A1 (de) |
EP (1) | EP2218457B1 (de) |
AT (1) | ATE523204T1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201220899D0 (en) * | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived pegylated peptides |
GB201220889D0 (en) * | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived peptides for treating metastasizing cancers |
GB201220891D0 (en) | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived peptides for treating breast cancers |
GB201220901D0 (en) * | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived peptides for treating pancreatic cancer |
GB201421647D0 (en) | 2014-12-05 | 2015-01-21 | Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie | CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002521058A (ja) * | 1998-07-27 | 2002-07-16 | マイクロビアル テクニクス リミティッド | 肺炎連鎖球菌由来の核酸及びタンパク質 |
EP2311988A1 (de) * | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae-Antigene |
ES2343797T3 (es) | 2004-10-14 | 2010-08-10 | Karlsruher Institut Fur Technologie | Compuestos peptidicos y sus derivados para el tratamiento de enfermedades humanas mediante la inhibicion de la via de señalizacion por factores de crecimiento. |
GB0714963D0 (en) * | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
-
2009
- 2009-02-16 EP EP09002149A patent/EP2218457B1/de not_active Not-in-force
- 2009-02-16 AT AT09002149T patent/ATE523204T1/de not_active IP Right Cessation
-
2010
- 2010-02-16 US US12/658,949 patent/US20100305026A1/en not_active Abandoned
-
2012
- 2012-11-09 US US13/673,749 patent/US8933017B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20130072423A1 (en) | 2013-03-21 |
EP2218457B1 (de) | 2011-09-07 |
EP2218457A1 (de) | 2010-08-18 |
US20100305026A1 (en) | 2010-12-02 |
US8933017B2 (en) | 2015-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123052T1 (el) | Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa) | |
WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
NZ618571A (en) | Peptides and their use | |
AU2008334326A8 (en) | Recombinant bacteriophage for detection of nosocomial infection | |
ZA201106620B (en) | Axmi-001,axmi-002,axmi-030,axmi-035,and axmi-045:insecticidal proteins from bacillus thuringiensis and methods for their use | |
MX336242B (es) | Uso de los compuestos a base de lantibioticos del tipo b que tienen actividad antimicrobiana. | |
WO2010035107A3 (en) | Peptides and compositions for prevention of cell adhesion and methods of using same | |
MX355543B (es) | Macrociclos peptidomiméticos. | |
WO2010090860A3 (en) | Methods and compositions for treating bacterial infection | |
EP4014982A3 (de) | Zusammensetzung zur induzierung der proliferation oder akkumulation von regulatorischen t-zellen | |
ZA201009074B (en) | Axmi-115,axmi-113,axmi-005,axmi-163 and axmi-184:vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
MX2012010671A (es) | Compuestos antiinfecciosos. | |
IN2012DN00829A (de) | ||
EP2730576A3 (de) | Antiinfektiöse Verbindungen | |
CL2012001080A1 (es) | Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida. | |
ATE523204T1 (de) | Cd44v6-peptide als bakterielle infektionsinhibitoren | |
MX344166B (es) | Leptina-polipeptidos modificados y sus usos. | |
EP2381954A4 (de) | Verfahren und zusammensetzungen auf der basis von shigatoxin-typ-2-protein | |
SG10201809286XA (en) | Biologically active peptides | |
MX2008007808A (es) | Analogos de rifamicina y usos de ellos. | |
IN2012DN02624A (de) | ||
EP2588121A4 (de) | C5a-analoga und verwendungsverfahren dafür | |
GB201009861D0 (en) | OMV vaccines | |
MX356959B (es) | Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos. | |
WO2010134827A9 (en) | Extended acting oxygen generating composition for treating microbial infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |